Together, these data demonstrate that tMSLC-derived C5a activates C5aR1 signaling in glioblastoma to enhance proliferation, stemness, and invasion, whereas W54011 treatment disrupts this signaling and restores tumor cells to a less aggressive state (Fig. 6). Here, C5AR1 is linked to glioblastoma.